| Epstein–Barr virus maintains lymphomas via its miRNAs DT Vereide, E Seto, YF Chiu, M Hayes, T Tagawa, A Grundhoff, ... Oncogene 33 (10), 1258-1264, 2014 | 185 | 2014 |
| A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection JA Bristol, R Djavadian, ER Albright, CB Coleman, M Ohashi, M Hayes, ... PLoS pathogens 14 (7), e1007179, 2018 | 90 | 2018 |
| Multiple functions are mediated by the miRNAs of Epstein-Barr virus M Kuzembayeva, M Hayes, B Sugden Current opinion in virology 7, 61-65, 2014 | 59 | 2014 |
| CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms R Djavadian, M Hayes, E Johannsen PLoS pathogens 14 (6), e1007114, 2018 | 51 | 2018 |
| Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment W Wang, A Uberoi, M Spurgeon, E Gronski, V Majerciak, A Lobanov, ... PLoS pathogens 16 (1), e1008206, 2020 | 44 | 2020 |
| Kaposi’s sarcoma–associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally YF Chiu, AU Sugden, K Fox, M Hayes, B Sugden Journal of Cell Biology 216 (9), 2745-2758, 2017 | 35 | 2017 |
| EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in … C Li, JC Romero-Masters, S Huebner, M Ohashi, M Hayes, JA Bristol, ... PLoS Pathogens 16 (6), e1008590, 2020 | 27 | 2020 |
| Using organotypic epithelial tissue culture to study the human papillomavirus life cycle D Lee, K Norby, M Hayes, YF Chiu, B Sugden, PF Lambert Current protocols in microbiology 41 (1), 14B. 8.1-14B. 8.19, 2016 | 25 | 2016 |
| Stress keratin 17 expression in head and neck cancer contributes to immune evasion and resistance to immune-checkpoint blockade W Wang, T Lozar, AE Golfinos, D Lee, E Gronski, E Ward-Shaw, M Hayes, ... Clinical Cancer Research 28 (13), 2953-2968, 2022 | 21 | 2022 |
| Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells JA Bristol, J Brand, M Ohashi, MR Eichelberg, A Casco, SE Nelson, ... PloS Pathogens 18 (4), e1010453, 2022 | 16 | 2022 |
| Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes M Ohashi, M Hayes, K McChesney, E Johannsen PLoS Pathogens 17 (3), e1009419, 2021 | 12 | 2021 |
| An EBNA3A-mutated Epstein-Barr virus retains the capacity for lymphomagenesis in a cord blood-humanized mouse model JC Romero-Masters, M Ohashi, R Djavadian, MR Eichelberg, M Hayes, ... Journal of virology 94 (10), 10.1128/jvi. 02168-19, 2020 | 11 | 2020 |
| Accurate quantification of overlapping herpesvirus transcripts from RNA sequencing data A Casco, A Gupta, M Hayes, R Djavadian, M Ohashi, E Johannsen Journal of Virology 96 (2), e01635-21, 2022 | 9 | 2022 |
| Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes DR Singh, SE Nelson, AS Pawelski, JA Cantres-Velez, AS Kansra, ... PLoS Pathogens 18 (10), e1010868, 2022 | 6 | 2022 |
| MmuPV1 E6 induces cell proliferation and other hallmarks of cancer JC Romero-Masters, LK Muehlbauer, M Hayes, M Grace, E Shishkova, ... Mbio 14 (6), e02458-23, 2023 | 1 | 2023 |
| Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice JA Bristol, SE Nelson, M Ohashi, A Casco, M Hayes, EA Ranheim, ... Plos Pathogens 20 (4), e1012132, 2024 | | 2024 |
| Optimal LentiCRISPR-Based System for Sequential CRISPR/Cas9 Screens RL Hutcheson, M Hayes, B Sugden ACS synthetic biology 11 (7), 2259-2266, 2022 | | 2022 |
| Correction: Kaposi’s sarcoma–associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally YF Chiu, AU Sugden, K Fox, M Hayes, B Sugden Journal of Cell Biology 217 (10), 3766-3767, 2018 | | 2018 |
